Osteoporosis management in long-term care. Survey of Ontario physicians.
- 1 November 2000
- journal article
- Vol. 46, 2228-35
Abstract
To survey physicians in Ontario regarding their approach to diagnosis and treatment of osteoporosis among residents of long-term care facilities. Mailed questionnaire covering physician demographics; current clinical practice relating to osteoporosis; and perceived barriers to prevention, diagnosis, and treatment of the disease. Long-term care facilities in Ontario. Medical directors of long-term care facilities. Demographic variables; physician attitudes; and practices concerning awareness, diagnosis, and treatment of osteoporosis. Respondents returned 275 of 490 questionnaires, for a response rate of 56.1%. Most respondents (92.4%) were family physicians; 28.7% were caring for more than 100 patients in long-term care. Most (85.8%) saw from one to 10 hip fractures yearly in their practices. Although 49.6% of respondents estimated the prevalence of osteoporosis to be 40% to 80% among their long-term care patients, 45.5% said that they did not routinely assess their patients for the disease, and 26.8% do not routinely treat it. Half (50.9%) of physicians would treat patients at high risk based on clinical history; 47.9% if patients had a vertebral compression fracture on plain x-ray examination; 43.8% if patients were highly functional; 42.0% if osteoporosis were confirmed with bone mineral densitometry; and 30.0% if patients had a recent fracture. Perceived barriers to initiating treatment included cost of therapy, patient or family reluctance to accept therapy, and time or cost of diagnosis. Although physicians are aware that patients in long-term care facilities are at high risk for osteoporosis and hip fractures, the disease remains underdiagnosed and undertreated.This publication has 23 references indexed in Scilit:
- Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines.1997
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- The Risks of Hip Fracture in Older People from Private Homes and InstitutionsAge and Ageing, 1996
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly womenBMJ, 1994
- Effect of external hip protectors on hip fracturesThe Lancet, 1993
- Vitamin D3and Calcium to Prevent Hip Fractures in Elderly WomenNew England Journal of Medicine, 1992
- Evidence for the effectiveness of CME. A review of 50 randomized controlled trials.1992
- Perspective how many women have osteoporosis?Journal of Bone and Mineral Research, 1992
- Annual injection of vitamin D and fractures of aged bonesCalcified Tissue International, 1992